SCHEMBL6681885

SCHEMBL6681885

CN(C)CC1CC/C(=C\c2ccc(Cl)cc2)C=C1c1cccc(O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.42
MITF O75030 1/20 0.42
CCR6 P51684 3/20 0.37
OPRK1 P41145 3/20 0.35
OPRD1 P41143 7/20 0.35
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
HSD11B1 P28845 1/20 0.33
OPRM1 P35372 3/20 0.33
SIGMAR1 Q99720 1/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PRKCZ Q05513 1/20 0.32
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681890 1.00 HSP90AA1 (0.42) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6677930 0.90 HSP90AA1 (0.42) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6677441 0.90 HSP90AA1 (0.42) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6677431 0.90 HSP90AA1 (0.42) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6677991 0.86 CCR6 (0.48) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6677990 0.86 CCR6 (0.48) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6718866 0.86 CCR6 (0.48) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6681695 0.86 CCR6 (0.48) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6680237 0.84 HSP90AA1 (0.37) HSP90AA1MITFCCR6OPRK1OPRD1
SCHEMBL6678188 0.84 HSP90AA1 (0.37) HSP90AA1MITFCCR6OPRK1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US claimed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US claimed
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP disclosed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US disclosed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives PTGER1, CYP2E1, HRH2 HSP90AA1 1652/4885MITF 1500/4885CCR6 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.